These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 15866057
1. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals. Palomo IG, Mujica VE, Alarcón ML, Pereira JG, Vásquez MR. J Diabetes Complications; 2005; 19(3):133-7. PubMed ID: 15866057 [Abstract] [Full Text] [Related]
2. Study of antiphospholipid antibodies in type 2 diabetes mellitus with and without diabetic retinopathy. Cojocaru IM, Cojocaru M, Popescu AN, Popescu L, Tănăsescu R. Rom J Intern Med; 2009; 47(3):267-71. PubMed ID: 20446442 [Abstract] [Full Text] [Related]
3. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis. Deeb A, Hamdoun S, Dababo K. Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789 [Abstract] [Full Text] [Related]
4. Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis. Palomo I, Pereira J, Alarcón M, Vásquez M, Pinochet C, Vélez MT, Sandoval J, Icaza G, Pierangeli S. Clin Rheumatol; 2004 Apr; 23(2):129-33. PubMed ID: 15045627 [Abstract] [Full Text] [Related]
5. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasquez M, Velez MT, Leon M, Espinola R, Pierangeli S. J Lab Clin Med; 2002 Nov; 140(5):336-41. PubMed ID: 12434135 [Abstract] [Full Text] [Related]
6. Antiphospholipid (aPL) antibodies in end-stage renal disease. Fabrizi F, Sangiorgio R, Pontoriero G, Corti M, Tentori F, Troina E, Locatelli F. J Nephrol; 1999 Nov; 12(2):89-94. PubMed ID: 10378664 [Abstract] [Full Text] [Related]
7. [Antiphospholipid syndrome and stroke]. Kitagawa Y. Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [Abstract] [Full Text] [Related]
8. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A, Kickler TS, Petri M. J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [Abstract] [Full Text] [Related]
9. Beta 2-glycoprotein I is a good indicator of certain adverse pregnancy conditions. Ulcová-Gallová Z, Bouse V, Krizanovská K, Balvín M, Rokyta Z, Netrvalová L. Int J Fertil Womens Med; 2001 Sep; 46(6):304-8. PubMed ID: 11795690 [Abstract] [Full Text] [Related]
10. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke. Cojocaru IM, Cojocaru M, Tănăsescu R, Burcin C, Mitu AC, Iliescu I, Dumitrescu L, Pavel I, Silosi I. Rom J Intern Med; 2008 Sep; 46(4):337-41. PubMed ID: 19480300 [Abstract] [Full Text] [Related]
11. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. Marie I, Jouen F, Hellot MF, Levesque H. Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496 [Abstract] [Full Text] [Related]
12. Identification of thrombin antibodies in patients with antiphospholipid syndrome. Miesbach W, Matthias T, Scharrer I. Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540 [Abstract] [Full Text] [Related]
13. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Arthritis Rheum; 2008 Apr 15; 59(4):561-7. PubMed ID: 18383424 [Abstract] [Full Text] [Related]
14. Significant association of antiphospholipid antibodies and TNF-alpha: marker of severe atherogenic profile of patients with type II diabetes mellitus without micro and/or macrovascular complications. Becarevic M, Seferovic J, Ignjatovic S, Singh S, Majkic-Singh N. Cytokine; 2011 Aug 15; 55(2):301-6. PubMed ID: 21621418 [Abstract] [Full Text] [Related]
15. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M, Duzgun N, Tunc SE, Tutkak H. Clin Biochem; 2007 May 15; 40(8):526-30. PubMed ID: 17359958 [Abstract] [Full Text] [Related]
17. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE. Ann Rheum Dis; 2008 Mar 15; 67(3):395-401. PubMed ID: 17644539 [Abstract] [Full Text] [Related]
18. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. Hasegawa EM, Caleiro MT, Fuller R, Carvalho JF. Lupus; 2009 Jun 15; 18(7):618-21. PubMed ID: 19433462 [Abstract] [Full Text] [Related]
19. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170 [Abstract] [Full Text] [Related]